OSH is underdog. Look at PE, it is still too expensive. No wonder why last 12 months it is struggling to moev north and hence trading at same price
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025